AdvaMed public affairs turnover
This article was originally published in The Gray Sheet
Executive Summary
Mary Anne Hansan will return to Porter Novelli at the end of April after less than six months of directing communications for the medical device trade group. Her tenure marks the second consecutive short-term stint for an AdvaMed VP-public affairs; in July 2004, Lisa Wolfington left the association after holding the title for roughly one year (1"The Gray Sheet" Nov. 22, 2004, In Brief). Hansan's successor likely will wait to take cues from a new president, as the search continues for Pam Bailey's replacement. Prior to joining AdvaMed, Hansan was VP-consumer group at Porter Novelli...
You may also be interested in...
AdvaMed rebranding
VP-public affairs will be Porter Novelli's current VP-Consumer Group Mary Anne Hansan. She joins the trade association Nov. 30, replacing Lisa Wolfington, who left in June. At the Washington, D.C. office of the PR firm, Hansan led "consumer brand and safety communications" for the propane industry, AdvaMed notes. She has served as a media contact for the American Chemistry Council and advertising director of the American Plastics Council. Soon after her arrival, Hansan will choose a director of media relations - a spot to be vacated by Jeff Ezell Dec. 1. Ezell will focus on "brand awareness" for diagnostic member companies (1"The Gray Sheet" Nov. 8, 2004, In Brief). An exec-VP-federal government relations post - formerly occupied by Steve Ubl, who left to form his own consultancy in July - remains to be filled. AdvaMed's board convenes in Washington, D.C. Dec. 8-9...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.